BioPharma M&A Drives More Efficient Resource Allocation By improving the efficiency of allocating the scarce resources of talent, science, and capital across the sector, biopharma M&A drives huge benefits – and much of biotech’s current success in advancing innovation stems from these long term positive impacts.